Geoffrey M. Price Sells 147,511 Shares of Oak Street Health, Inc. (NYSE:OSH) Stock

Oak Street Health, Inc. (NYSE:OSHGet Rating) insider Geoffrey M. Price sold 147,511 shares of Oak Street Health stock in a transaction on Tuesday, August 2nd. The stock was sold at an average price of $30.03, for a total transaction of $4,429,755.33. Following the completion of the transaction, the insider now directly owns 1,395,759 shares in the company, valued at $41,914,642.77. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Oak Street Health Stock Up 2.4 %

Shares of Oak Street Health stock opened at $30.29 on Friday. The company has a quick ratio of 1.79, a current ratio of 1.79 and a debt-to-equity ratio of 16.10. The firm has a market cap of $7.30 billion, a P/E ratio of -13.77 and a beta of 3.05. Oak Street Health, Inc. has a fifty-two week low of $13.29 and a fifty-two week high of $64.75. The business has a 50-day moving average price of $21.54 and a 200 day moving average price of $20.69.

Oak Street Health (NYSE:OSHGet Rating) last announced its quarterly earnings data on Tuesday, May 3rd. The company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.04). The firm had revenue of $513.80 million during the quarter, compared to the consensus estimate of $506.82 million. Oak Street Health had a negative net margin of 27.11% and a negative return on equity of 716.26%. The firm’s quarterly revenue was up 73.2% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.29) earnings per share. On average, sell-side analysts forecast that Oak Street Health, Inc. will post -2.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently commented on OSH shares. Argus started coverage on shares of Oak Street Health in a report on Tuesday, July 26th. They set a “hold” rating on the stock. Barclays upped their price target on shares of Oak Street Health from $27.00 to $31.00 and gave the company an “overweight” rating in a research report on Tuesday, April 19th. SVB Leerink increased their target price on shares of Oak Street Health from $23.00 to $32.00 and gave the stock a “market perform” rating in a report on Thursday. Stifel Nicolaus upped their price target on Oak Street Health from $25.00 to $35.00 in a research note on Wednesday, July 27th. Finally, UBS Group raised their price target on Oak Street Health from $26.00 to $28.00 and gave the stock a “neutral” rating in a research report on Wednesday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $35.50.

Hedge Funds Weigh In On Oak Street Health

Several institutional investors have recently made changes to their positions in OSH. Capital Research Global Investors grew its holdings in shares of Oak Street Health by 61.0% during the first quarter. Capital Research Global Investors now owns 11,852,080 shares of the company’s stock valued at $318,584,000 after purchasing an additional 4,491,941 shares during the last quarter. Maverick Capital Ltd. grew its holdings in shares of Oak Street Health by 1,464.9% during the fourth quarter. Maverick Capital Ltd. now owns 4,225,127 shares of the company’s stock valued at $140,021,000 after purchasing an additional 3,955,127 shares during the last quarter. Route One Investment Company L.P. grew its holdings in shares of Oak Street Health by 92.9% during the first quarter. Route One Investment Company L.P. now owns 5,725,037 shares of the company’s stock valued at $153,889,000 after purchasing an additional 2,756,500 shares during the last quarter. Eminence Capital LP bought a new position in shares of Oak Street Health during the first quarter valued at approximately $73,233,000. Finally, Capital World Investors grew its holdings in shares of Oak Street Health by 44.5% during the fourth quarter. Capital World Investors now owns 5,966,260 shares of the company’s stock valued at $197,722,000 after purchasing an additional 1,836,533 shares during the last quarter. 91.42% of the stock is owned by institutional investors.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Further Reading

Insider Buying and Selling by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.